Latest California Healthline Stories
Change to Gilead Assistance Program Threatens PrEP Access, HIV Advocates Say
Safety-net clinics especially are bracing for how the drugmaker’s policy shift could reduce their budgets and hamstring their ability to provide care to an at-risk population.
Lawmakers Pressure Newsom to ‘Step Up’ on Racism as a Public Health Issue
California Democratic lawmakers are asking Gov. Gavin Newsom to approve $100 million per year to fund programs that address health inequality and structural racism.
Can a Subscription Model Fix Primary Care in the US?
Medical subscriptions, a $199 million CEO payday and the race to fix primary care in the U.S. One Medical is betting big that a subscription model can fix primary care. But the firm faces competition from CVS, Target and large hospital systems.
An Anti-Vaccine Film Targeted to Black Americans Spreads False Information
A new movie produced by Robert F. Kennedy Jr.’s anti-vaccine group tries to capitalize on the covid-19 pandemic, the racial justice movement and renewed interest in the history of medical racism.
Women Now Drink as Much as Men — And Are Prone to Sickness Sooner
Young women have closed the gender gap for excessive drinking. And that was before the pandemic. The trend is particularly troubling because women are at greater risk for blackouts, liver disease, cardiovascular diseases and certain cancers linked to alcohol use.
Trying to Avoid Racist Health Care, Black Women Seek Out Black Obstetricians
Besides shared culture and values, a Black physician can offer Black patients a sense of safety, validation and trust. By contrast, the impact of systemic racism can show up starkly in childbirth. Black women are three times as likely to die after giving birth as white women in the United States.
Montana Med School Clash Revives For-Profit Vs. Nonprofit Flap
Two medical schools vie to open in Montana, highlighting the rapid spread of for-profit schools and their previously tarnished business model.
Analysis: Mounting Pressure on China About Covid ‘Lab Leak’ Could Backfire
Where the coronavirus originated remains a mystery and the Chinese are bucking demands to let investigators see more.
FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy
The agency is to decide by June 7 whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November. Some scientists at the agency have endorsed the drug, though.
KHN’s ‘What the Health?’: The Drug Price Dilemma
Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.